Wyeth

BMS appoints Judge as senior vice president, human resources

Thursday, February 21, 2013 08:00 AM

Global biopharmaceutical company Bristol-Myers Squibb (BMS) has appointed Ann Powell Judge as senior vice president, Human Resources.

More... »


Pfizer’s Karen Bien elected to board of SAFE-BioPharma

Friday, June 29, 2012 09:57 AM

Karen Bien, director of business technology on Pfizer’s acquisition, collaboration and divestiture team, has been elected to the board of directors of SAFE-BioPharma Association, the strategic non-profit collaboration that developed and manages the global SAFE-BioPharma digital identity and digital signature standard for the life science and healthcare sectors.

More... »


Paratek appoints Molnar and Loh to senior positions

Thursday, May 24, 2012 09:00 AM

Paratek Pharmaceuticals of Boston, Mass., has named Dennis Molnar as director, president and CEO, and Evan Loh, MD, as chief medical officer and chairman of the board of directors.  

More... »

Dendreon appoints three to executive team

Wednesday, March 14, 2012 09:10 AM

Seattle, Wash.-based Dendreon has appointed three new members to its executive team:

More... »

Intellect Neurosciences to appeal in European patent proceedings

Wednesday, February 15, 2012 03:30 PM

Intellect Neurosciences, a biopharmaceutical company focused on disease-modifying therapeutic agents for Alzheimer's disease, submitted a statement setting out its grounds for appealing the European Patent Office's (EPO) preliminary decision to revoke the company's Antisenilin (bapineuzumab) patents.

More... »

Roese joins Marken

Thursday, December 22, 2011 11:29 AM
Marken has named Steve Roese vice president of its global quality assurance organization, which will support Marken's continued investment in their expanding network of pharmaceutical service depots around the world.

More... »

Tornoe joins Exagen Diagnostics

Wednesday, August 10, 2011 11:09 AM

Exagen Diagnostics has named Eric Tornoe its president and chief operating officer.

More... »

Pfizer backs out of pact with Biotica

Thursday, August 4, 2011 11:12 AM

Pfizer has returned the rights to a rapamycin analogue program it has been running to explore the potential of diseases such as multiple sclerosis and lupus to the UK's Biotica Technology, according to PharmaTimes.

More... »

Cytel names Jim Baker VP

Tuesday, March 22, 2011 12:00 PM

Cambridge, Mass.-based Cytel, a provider of clinical trial design and implementation services and software, has named Jim Baker vice president of clinical research services.

More... »

CenterWatch Monthly March 2009

Thursday, March 5, 2009 08:00 AM

Pharma Consolidation Slows CRO Market in Short Term

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs